All practice questions

4736 questions

Question 3261Question →

A 71-year-old man is admitted to the intensive care unit with a 3-day history of worsening confusion, severe weakness, and diffuse abdominal pain with constipation. He has a history of squamous cell carcinoma of the lung with diffuse metastases to the ribs and thoracic spine. The patient has been unable to drink fluids for the past 2 days due to profound nausea. Vital signs show temperature 37.2∘C37.2^\circ\text{C}, heart rate 118/min118\text{/min}, blood pressure 92/58 mmHg92/58\text{ mmHg}, and respiratory rate 18/min18\text{/min}. Physical examination reveals a somnolent patient who withdraws from painful stimuli. His mucous membranes are extremely dry, and skin turgor is significantly decreased.

Initial laboratory studies reveal:
Serum sodium: 148 mEq/L148\text{ mEq/L}
Serum potassium: 4.2 mEq/L4.2\text{ mEq/L}
Serum chloride: 106 mEq/L106\text{ mEq/L}
Serum bicarbonate: 24 mEq/L24\text{ mEq/L}
Blood urea nitrogen: 82 mg/dL82\text{ mg/dL}
Serum creatinine: 4.8 mg/dL4.8\text{ mg/dL} (baseline 1.2 mg/dL1.2\text{ mg/dL})
Serum total calcium: 16.2 mg/dL16.2\text{ mg/dL}
Serum albumin: 3.0 mg/dL3.0\text{ mg/dL}
Serum phosphorus: 2.1 mg/dL2.1\text{ mg/dL}

Aggressive intravenous hydration with 0.9%0.9\% normal saline and administration of subcutaneous calcitonin are immediately initiated. Which of the following is the most appropriate additional pharmacologic intervention to provide sustained control of this patient's hypercalcemia?

Show answer & explanation

Answer: Subcutaneous denosumab

Answer

Subcutaneous denosumab is the most appropriate intervention for sustained calcium control because it is not nephrotoxic and can be safely used in the setting of severe acute kidney injury.
The correct answer is subcutaneous denosumab. This patient presents with severe hypercalcemia of malignancy (HCM) and a superimposed acute kidney injury (AKI). The immediate management of severe HCM requires aggressive intravenous isotonic fluid resuscitation to restore intravascular volume and calcitonin for a rapid decline in serum calcium. Because calcitonin's effect is transient (tachyphylaxis occurs within 48 hours), a long-acting bone resorption inhibitor must be administered concurrently. While intravenous bisphosphonates are traditionally first-line for sustained control, they are highly nephrotoxic and contraindicated in patients with severe renal impairment (e.g., serum creatinine >4.5 mg/dL> 4.5\text{ mg/dL} or CrCl <30 mL/min< 30\text{ mL/min}). Denosumab is a monoclonal antibody that binds to the receptor activator of nuclear factor kappa-B ligand (RANKL), preventing osteoclast activation. It is not cleared by the kidneys, lacks nephrotoxicity, and is the preferred guideline-supported agent for long-term calcium control in HCM patients with severe AKI.

Step-by-Step Solution

1
Determine the severity and etiology of the metabolic derangement.
The patient has severe hypercalcemia of malignancy (corrected calcium = 17.0 mg/dL) driven by squamous cell carcinoma (likely PTHrP-mediated or due to osteolytic bone metastases).
Corrected calcium >14 mg/dL> 14\text{ mg/dL} is a life-threatening emergency requiring immediate multi-modal treatment.
2
Evaluate the patient's renal function based on laboratory values.
The patient has a severe acute kidney injury (AKI) with a serum creatinine of 4.8 mg/dL4.8\text{ mg/dL} (baseline 1.2 mg/dL1.2\text{ mg/dL}), likely prerenal from hypercalcemia-induced nephrogenic diabetes insipidus and poor oral intake.
Renal function strictly dictates which long-term calcium-lowering pharmacotherapies can be safely administered.
3
Select the appropriate class of medication for sustained calcium control.
A long-acting bone resorption inhibitor must be administered concurrently with rapid-acting agents (fluids and calcitonin).
Calcitonin acts rapidly but exhibits tachyphylaxis within 48 hours, requiring a long-term agent to maintain normocalcemia.
4
Differentiate between available bone resorption inhibitors based on the patient's AKI.
Intravenous bisphosphonates (e.g., zoledronic acid) are contraindicated due to severe nephrotoxicity. Denosumab (a monoclonal antibody against RANKL) is selected.
Denosumab is cleared via the reticuloendothelial system rather than the kidneys, making it the safest and most effective choice for patients with severe renal impairment.

Key Concept

In patients with severe hypercalcemia of malignancy complicated by severe renal impairment (e.g., severe AKI or CrCl <30 mL/min< 30\text{ mL/min}), denosumab is the preferred long-acting bone resorption inhibitor over bisphosphonates, which are nephrotoxic and contraindicated.
Question 3262Question →

During a routine follow-up appointment, a 3434-year-old female is evaluated for persistently elevated blood pressure. She was diagnosed with hypertension six months ago and is currently adherent to a regimen of maximum-dose amlodipine, chlorthalidone, and lisinopril. Despite this therapy, her home blood pressure readings consistently range from 160/100160/100 to 175/110 mm Hg175/110 \text{ mm Hg}. The patient mentions occasional mild headaches but otherwise feels well. She does not smoke or consume alcohol. Family history is notable for hypertension in her father, diagnosed at age 5555.

Vital signs in the office today show a blood pressure of 168/104 mm Hg168/104 \text{ mm Hg} and a heart rate of 76/min76/\text{min}. Physical examination reveals a thin adult with a body mass index of 22 kg/m222 \text{ kg/m}^2. Cardiopulmonary examination is unremarkable. Auscultation of the abdomen reveals a soft, high-pitched systolic bruit over the right upper quadrant.

Laboratory studies are obtained and compared to baseline values from three weeks ago, just prior to the addition of lisinopril to her regimen:

Laboratory ParameterCurrent ValueBaseline (3 weeks ago)
Serum sodium139 mEq/L139 \text{ mEq/L}140 mEq/L140 \text{ mEq/L}
Serum potassium4.1 mEq/L4.1 \text{ mEq/L}4.0 mEq/L4.0 \text{ mEq/L}
Serum creatinine1.8 mg/dL1.8 \text{ mg/dL}0.9 mg/dL0.9 \text{ mg/dL}
Blood urea nitrogen24 mg/dL24 \text{ mg/dL}12 mg/dL12 \text{ mg/dL}

Which of the following is the most appropriate next step in the diagnostic workup?

Show answer & explanation

Answer: Renal duplex ultrasonography

Answer

Renal duplex ultrasonography
The correct approach for a patient with high clinical suspicion for renovascular hypertension (indicated by young age, resistant hypertension, an abdominal bruit, and an ACE inhibitor-induced acute kidney injury) is to perform non-invasive vascular imaging. Because this patient has a significantly elevated serum creatinine (1.8 mg/dL1.8 \text{ mg/dL}), tests requiring iodinated contrast pose a high risk of contrast-induced nephropathy. Renal duplex ultrasonography provides excellent sensitivity for detecting renal artery stenosis without utilizing nephrotoxic agents, making it the ideal initial test in this diagnostic sequence.

Step-by-Step Solution

1
Analyze the clinical presentation and identify the underlying syndrome.
The patient is a young female with resistant hypertension, an abdominal bruit, and an acute doubling of serum creatinine after starting an ACE inhibitor (lisinopril).
This constellation of findings is highly specific for bilateral renal artery stenosis or severe unilateral stenosis, likely due to fibromuscular dysplasia in this demographic.
2
Evaluate the current physiological state to guide safe test selection.
The patient has acute kidney injury, evidenced by the jump in serum creatinine from 0.9 mg/dL0.9 \text{ mg/dL} to 1.8 mg/dL1.8 \text{ mg/dL}.
Recognizing the acute kidney injury is critical because it dictates which imaging modalities are safe to use.
3
Determine the optimal sequence for diagnostic imaging.
Renal duplex ultrasonography is selected as the next step.
It is a highly sensitive and specific non-invasive screening tool that does not utilize nephrotoxic iodinated contrast or gadolinium, making it the safest initial test for a patient with compromised renal function.

Key Concept

In patients with suspected renovascular hypertension and impaired renal function (such as an ACE inhibitor-induced acute kidney injury), renal duplex ultrasonography is the preferred initial diagnostic imaging modality because it avoids the risk of contrast-induced nephropathy associated with CTA.
Estimated Time:1m 15s
Question 3263Question →

A 2727-year-old man presents to the emergency department with a 55-day history of abdominal pain. The pain initially began around his umbilicus and was associated with nausea and two episodes of nonbloody emesis. Three days ago, the pain migrated to the right lower quadrant and became more constant. Yesterday, he felt slightly better, but today he developed a fever and worsening, severe right lower quadrant pain. Temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 122/78 mmHg122/78\text{ mmHg}, pulse is 112/min112/\text{min}, and respirations are 18/min18/\text{min}. Physical examination reveals a palpable, tender, 6 cm6\text{ cm} mass in the right lower quadrant. Bowel sounds are hypoactive. Laboratory studies show a leukocyte count of 17,200/mm317,200/\text{mm}^3 with a neutrophil predominance. Computed tomography of the abdomen and pelvis with intravenous contrast reveals a ruptured appendix with an adjacent 5.2 cm5.2\text{ cm} rim-enhancing periappendiceal fluid collection. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intravenous antibiotics and percutaneous fluid drainage

Answer

Intravenous antibiotics and percutaneous fluid drainage
The correct approach to a patient presenting with appendicitis symptoms for more than 55 days and a confirmed abscess larger than 3 cm3\text{ cm} is nonoperative management with intravenous antibiotics and percutaneous image-guided drainage. In delayed presentations, the body has walled off the perforation, creating a mass of inflamed tissue and adherent bowel loops (phlegmon or abscess). Attempting an immediate appendectomy in this setting is technically difficult and carries a high complication rate, including iatrogenic enterotomy and the unintended need for an ileocecectomy or right hemicolectomy. After successful percutaneous drainage and resolution of the acute infection, the patient can be evaluated for an elective interval appendectomy several weeks later.

Step-by-Step Solution

1
Analyze the clinical presentation and timeline.
The patient has a 55-day history of RLQ pain, fever, tachycardia, and a palpable mass, suggesting a delayed presentation of appendicitis with complication.
Establishing the timeline of appendicitis is critical, as management changes significantly if symptoms have been present for >5>5 days.
2
Interpret the imaging findings.
CT scan confirms a ruptured appendix with a 5.2 cm5.2\text{ cm} abscess.
Fluid collections >3 cm>3\text{ cm} require different management than small phlegmons or early, uncomplicated appendicitis.
3
Select the appropriate procedural intervention.
Choose percutaneous CT-guided drainage combined with IV antibiotics over immediate surgery.
Immediate surgery in the setting of a large, late-presenting abscess carries a high risk of bowel injury and the need for ileocecal resection due to severe inflammation.

Key Concept

Management of late-presentation appendiceal abscess
Estimated Time:1m 0s
Question 3264Question →

A 58-year-old man with a history of stage 4 chronic kidney disease and heart failure is brought to the emergency department due to profound generalized muscle weakness and palpitations that began earlier today. His medications include lisinopril and newly prescribed spironolactone. His heart rate is 54/min, and blood pressure is 112/68 mmHg. An electrocardiogram reveals widened QRS complexes merging with tall, peaked T waves in a "sine wave" pattern. A point-of-care basic metabolic panel shows a serum potassium level of 8.4 mEq/L.

Arrange the following pharmacologic interventions in the most appropriate chronological sequence for the acute management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of administration is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and 50% dextrose, 3) Oral sodium zirconium cyclosilicate.
The fundamental algorithm for severe hyperkalemia with electrocardiographic changes dictates a strict temporal sequence based on the onset of action of each pharmacologic agent. First, myocardial cell membranes must be stabilized to prevent lethal arrhythmias, which is achieved rapidly (1-3 minutes) with intravenous calcium gluconate. Second, potassium must be temporarily redistributed into the intracellular compartment using intravenous regular insulin (accompanied by dextrose to prevent hypoglycemia); this process takes 15-30 minutes. Finally, total body potassium must be definitively reduced using gastrointestinal potassium binders such as sodium zirconium cyclosilicate, which have an onset of several hours. Proceeding in any other order leaves the patient vulnerable to sudden cardiac death.

Step-by-Step Solution

1
Identify the life-threatening emergency.
The patient has severe hyperkalemia (8.4 mEq/L) with critical ECG changes (widened QRS, sine wave pattern).
Recognizing sine wave morphology indicates impending cardiac arrest, necessitating immediate step-wise intervention.
2
Prioritize myocardial stabilization.
Select intravenous calcium gluconate as the immediate first intervention.
Calcium directly antagonizes the membrane actions of hyperkalemia. It restores the resting membrane potential difference, taking effect in 1-3 minutes to prevent fatal arrhythmias.
3
Initiate temporary potassium shifting.
Select intravenous regular insulin (with dextrose to prevent hypoglycemia) as the second intervention.
Once the heart is temporarily protected, serum potassium must be rapidly lowered. Insulin drives potassium into cells via Na+/K+-ATPase activation, acting within 15-30 minutes.
4
Establish definitive potassium removal.
Select oral sodium zirconium cyclosilicate as the final pharmacologic step in this sequence.
Calcium and insulin are temporary measures. A potassium binder removes total body potassium through the gastrointestinal tract, providing definitive but slower (hours) treatment.

Key Concept

The sequential management of severe hyperkalemia involves three distinct phases: immediate myocardial stabilization (calcium), rapid intracellular shifting (insulin/glucose), and definitive total body removal (cation exchange resins or loop diuretics).
Question 3265Question →

A 5858-year-old man is brought to the emergency department by his husband due to severe, worsening mid-back pain over the past week. The patient has a history of type 2 diabetes mellitus and intravenous substance use. Over the last 1212 hours, he has developed profound weakness in both legs and has been unable to urinate. His temperature is 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}), blood pressure is 118/76 mm Hg118/76\text{ mm Hg}, pulse is 108/min108/\text{min}, and respirations are 18/min18/\text{min}. Physical examination reveals marked tenderness to percussion over the midthoracic spine. Neurological examination shows 3/53/5 muscle strength in the bilateral lower extremities, decreased sensation to pinprick below the umbilicus, and hyperreflexia at the patellae with bilateral upgoing plantar reflexes. Digital rectal examination demonstrates decreased anal sphincter tone. Which of the following are the most appropriate immediate steps in this patient's diagnostic workup? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Urgent magnetic resonance imaging of the entire spine with gadolinium; Blood cultures from two separate peripheral sites

Answer

The correct diagnostic steps are urgent magnetic resonance imaging of the entire spine with gadolinium and blood cultures from two separate peripheral sites.
This patient's acute presentation of severe back pain, fever, and signs of spinal cord compression (lower extremity weakness, sensory level, bowel/bladder dysfunction, and hyperreflexia) in the setting of intravenous substance use is highly suspicious for a spinal epidural abscess (SEA). SEA is a neurosurgical emergency. The initial diagnostic workup must rapidly establish the anatomic extent of the disease and the causative organism without causing harm. Urgent magnetic resonance imaging (MRI) of the entire spine with gadolinium is the gold standard diagnostic test to visualize the epidural collection and the severity of cord compression. Concurrently, blood cultures must be drawn from two separate sites to identify the pathogen and allow for appropriately targeted long-term intravenous antibiotic therapy.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the patient's presentation.
The patient demonstrates the classic triad for a spinal epidural abscess (SEA): severe focal back pain, fever, and progressive neurological deficits (leg weakness, sensory level, urinary retention, and upper motor neuron signs).
Recognizing this neurological emergency is critical to prevent permanent paralysis and dictates immediate diagnostic sequencing.
2
Determine the optimal neuroimaging modality.
Urgent magnetic resonance imaging (MRI) of the spine with contrast is selected.
MRI is the most sensitive and specific test for diagnosing SEA, evaluating the exact location and size of the abscess, and assessing the degree of spinal cord compression to guide surgical decompression.
3
Select the appropriate initial laboratory workup for identifying the etiology.
Blood cultures from two separate venipuncture sites are selected.
Identifying the microbiologic cause (most commonly Staphylococcus aureus) is essential for tailoring long-term antibiotic therapy. Blood cultures are positive in approximately 60% of cases and must be drawn before initiating empiric antibiotics.

Key Concept

Patients presenting with signs of a spinal epidural abscess with cord compression require an immediate diagnostic workup consisting of an urgent spinal MRI with contrast and concurrent peripheral blood cultures to facilitate rapid neurosurgical intervention and targeted antimicrobial therapy.
Question 3266Question →

Paramedics transport an elderly female resident of an assisted living facility to the acute care unit. Staff at the facility reported she had been complaining of unremitting abdominal discomfort and had vomited several times over the prior half-day. She is 7272 years old. Her documented medical history is significant for chronic hypertension, paroxysmal atrial fibrillation, and a history of an open cholecystectomy a decade ago. Vital signs upon triage show a temperature of 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), a blood pressure of 85/50 mm Hg85/50\text{ mm Hg}, a heart rate of 128/min128/\text{min}, and a respiratory rate of 24/min24/\text{min}. Her abdomen is markedly distended. Palpation elicits diffuse guarding and rebound tenderness across all quadrants. Auscultation reveals a silent abdomen. Close inspection of the right lower quadrant demonstrates a prominent, non-reducible mass adjacent to her prior surgical scar. The skin overlying the mass is notably erythematous, warm to the touch, and exquisitely painful upon minimal contact. Which of the following interventions are indicated for this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Intravenous crystalloid resuscitation; Broad-spectrum intravenous antibiotics; Emergent surgical exploration

Answer

The correct steps are intravenous crystalloid resuscitation, broad-spectrum intravenous antibiotics, and emergent surgical exploration.
The clinical presentation is highly indicative of a strangulated incisional hernia complicated by bowel ischemia or perforation. This is evidenced by the exquisitely tender, erythematous hernia sac, absent bowel sounds, diffuse peritonitis, and signs of septic shock. In this scenario, the standard of care is immediate concurrent resuscitation with intravenous fluids and broad-spectrum antibiotics, followed immediately by definitive procedural intervention via emergent surgical exploration. Delaying surgery for imaging or attempting manual reduction can be fatal.

Step-by-Step Solution

1
Assess the patient's hemodynamic status and vital signs.
The patient is hypotensive, tachycardic, and febrile, which indicates the presence of septic shock.
Recognizing hemodynamic instability prioritizes immediate resuscitation over diagnostic testing.
2
Evaluate the localized and systemic physical examination findings.
The patient has a tender, erythematous right lower quadrant mass near a surgical scar, accompanied by diffuse peritonitis.
These findings are diagnostic for a strangulated incisional hernia with resulting bowel ischemia.
3
Determine the appropriate combination of interventions.
The patient requires immediate fluid resuscitation, broad-spectrum antibiotics, and direct transfer to the operating room.
Definitive surgical intervention is life-saving; delaying for imaging or attempting reduction are dangerous missteps.

Key Concept

In patients with a strangulated hernia and peritonitis, immediate management requires concurrent hemodynamic resuscitation, broad-spectrum antibiotics, and emergent surgical exploration.
Estimated Time:1m 30s
Question 3267Question →

A 26-year-old man with a known history of ulcerative colitis is admitted to the hospital with an acute flare. He reports 10 to 12 bloody bowel movements daily and severe lower abdominal pain. His temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), blood pressure is 110/70 mm Hg110/70 \text{ mm Hg}, and heart rate is 118/min118/min. Laboratory results show a hemoglobin of 9.8 g/dL9.8 \text{ g/dL}, leukocyte count of 14,000/μL14,000/\mu\text{L}, and C-reactive protein (CRP) of 90 mg/L90 \text{ mg/L}. A diagnosis of acute severe ulcerative colitis (ASUC) is made.

Arrange the following steps in the standard evidence-based chronological sequence for the therapeutic management and monitoring of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The standard sequence is: rule out infections and start IV steroids, monitor closely for acute complications like toxic megacolon, formally evaluate the treatment response on days 3 to 5, escalate to medical rescue therapy if steroid-refractory, and finally de-escalate to an oral taper once clinical remission is achieved.
The standard evidence-based protocol for acute severe ulcerative colitis (ASUC) relies on a stepwise escalation and de-escalation framework centered around rigorous monitoring and treatment evaluation. It begins with ruling out superimposed infections and immediately initiating high-dose IV corticosteroids. Because ASUC carries a high short-term complication rate, intensive daily monitoring for toxic megacolon is crucial during the early stages of therapy. The hallmark of ASUC management is the mandatory treatment evaluation between hospital days 3 and 5 (using indices like the Oxford criteria, which rely on stool frequency and CRP). If the patient is determined to be steroid-refractory at this specific interval, the standard of care dictates immediate escalation to medical rescue therapy (infliximab or cyclosporine) or surgical colectomy. Finally, only after achieving clinical stability and remission, the patient is transitioned to an oral steroid taper alongside long-term maintenance therapy.

Step-by-Step Solution

1
Exclude infection and start initial induction therapy
The patient begins intravenous corticosteroid therapy safely without exacerbating a hidden infection.
Enteric infections can trigger flares and complicate immunosuppression. IV steroids remain the first-line gold standard for ASUC induction.
2
Conduct rigorous daily clinical monitoring
The patient is closely monitored for colonic dilation, systemic toxicity, and deterioration.
Patients receiving initial high-dose steroids are at the highest risk for acute complications like toxic megacolon during the first 72 hours.
3
Evaluate treatment efficacy at the required interval
The clinical trajectory is objectively assessed on hospital days 3 to 5 using markers like CRP and daily stool frequency.
Evidence-based guidelines mandate a formal assessment at 72 to 120 hours to identify non-responders and prevent the risks of prolonged, ineffective steroid exposure.
4
Escalate to rescue therapy if indicated
Rescue medical therapy (e.g., infliximab) or surgical intervention is implemented.
Failure to meet objective response criteria by day 5 signifies steroid-refractory disease, requiring immediate escalation to alter the disease course.
5
De-escalate to outpatient maintenance therapy
The patient is transitioned to oral corticosteroids with a tapering plan and a long-term maintenance drug.
After the acute flare is resolved, management shifts to maintaining remission and minimizing the adverse effects of chronic corticosteroid use.

Key Concept

The management of acute severe ulcerative colitis follows a highly structured sequence: initial IV corticosteroids, rigorous complication monitoring, mandatory objective response evaluation between days 3 and 5, escalation to rescue therapy if refractory, and eventual transition to an oral taper for maintenance.
Question 3268Question →

A 4242-year-old man is brought to the emergency department after a high-speed motorcycle crash. He is agitated, pale, and diaphoretic. His temperature is 36.2∘C36.2^\circ C, heart rate is 142/min142/min, blood pressure is 76/4076/40 mmHg, and respiratory rate is 28/min28/min. The airway is patent, and breath sounds are present and equal bilaterally. A cervical spine collar is in place. The abdomen is grossly distended and rigid, with diffuse tenderness to palpation. The pelvis is mechanically stable to anterior-posterior and lateral compression. Bedside focused assessment with sonography for trauma (FAST) demonstrates a large amount of anechoic fluid in the hepatorenal and splenorenal recesses. Two large-bore intravenous lines are placed, and balanced crystalloid resuscitation is initiated alongside an uncrossmatched blood transfusion. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Immediate exploratory laparotomy

Answer

Immediate exploratory laparotomy
The correct answer is immediate exploratory laparotomy. In the algorithm for blunt abdominal trauma, any patient who presents with hemodynamic instability (e.g., severe hypotension and tachycardia) and has a positive FAST exam is presumed to have a life-threatening intra-abdominal hemorrhage. These patients must be transported immediately to the operating room for surgical exploration to arrest the bleeding. Resuscitation with blood products should occur simultaneously with surgical control.

Step-by-Step Solution

1
Assess the patient's hemodynamic status.
The patient is in class III/IV hemorrhagic shock, evidenced by severe hypotension (76/4076/40 mmHg) and significant tachycardia (142/min142/min).
Identifying hemodynamic instability dictates whether the patient can safely undergo time-consuming imaging or requires immediate resuscitation and surgery.
2
Evaluate the primary source of hemorrhage using adjuncts like the FAST exam.
The FAST exam is positive, showing anechoic fluid (blood) in the dependent spaces of the abdominal cavity.
In the setting of blunt trauma, a positive FAST rapidly confirms the abdomen as the source of life-threatening hemorrhage.
3
Determine the definitive treatment setting.
The combination of hemodynamic instability and confirmed intraperitoneal hemorrhage mandates surgical exploration.
Non-operative management or advanced imaging is strictly reserved for hemodynamically stable patients.

Key Concept

Hemodynamically unstable patients with blunt abdominal trauma and a positive FAST exam require emergent exploratory laparotomy.
Estimated Time:1m 0s
Question 3269Question →

A multidisciplinary rounding team is determining the optimal discharge pathway for a 78-year-old man who has been hospitalized for six days due to methicillin-resistant *Staphylococcus aureus* bacteremia secondary to a cellulitis infection. He has been afebrile for 48 hours, and repeat blood cultures show no growth. Vital signs are normal, except for a heart rate of 92/min. Laboratory studies show a white blood cell count of 11,200/mm311,200/\mathrm{mm}^3 (down from 18,500/mm318,500/\mathrm{mm}^3 on admission) and a serum creatinine of 1.3 mg/dL1.3\text{ mg/dL} (baseline 1.2 mg/dL1.2\text{ mg/dL}). The infectious disease service recommends an additional four weeks of intravenous vancomycin. Prior to admission, the patient lived alone and was completely independent. Currently, due to profound deconditioning, he requires moderate assistance with bed-to-chair transfers and ambulates less than 10 feet with a walker. Therapy evaluations note that he fatigues rapidly, tolerating a maximum of 45 minutes of active physical and occupational therapy per day. His nearest relative lives in another state. Which of the following is the most appropriate care setting transition for this patient?

Show answer & explanation

Answer: Skilled nursing facility

Answer

Skilled nursing facility
The correct answer identifies a skilled nursing facility as the optimal care setting. This patient is hemodynamically stable and no longer requires acute medical-surgical hospital care, but he needs ongoing skilled nursing care (intravenous antibiotics) and rehabilitation (physical therapy for profound deconditioning). Because he can only tolerate 45 minutes of therapy per day and requires assistance with transfers while living alone without a caregiver, a skilled nursing facility is the safest and most appropriate disposition. These facilities provide subacute medical care alongside lower-intensity rehabilitation typically ranging from 1 to 2 hours per day.

Step-by-Step Solution

1
Evaluate the patient's ongoing medical and nursing requirements.
The patient needs an additional 4 weeks of intravenous vancomycin.
Intravenous medication administration requires skilled nursing oversight, which dictates the baseline level of care required outside of an acute hospital.
2
Assess the patient's functional status, rehabilitation capacity, and social support.
The patient requires moderate assistance with transfers, tolerates only 45 minutes of therapy per day, and lives entirely alone.
Functional capacity and home support determine whether the patient can safely return home or must transition to an inpatient post-acute care setting (and at what intensity).
3
Synthesize the data to match the patient with the correct facility criteria.
A skilled nursing facility is chosen over home, an inpatient rehabilitation facility, or a long-term acute care hospital.
A skilled nursing facility provides the required IV antibiotic administration, custodial assistance with transfers, and a lower-intensity rehabilitation program suited to a patient who fatigues quickly.

Key Concept

Disposition to post-acute care settings requires matching a patient's medical acuity (e.g., IV antibiotics), rehabilitation endurance (ability to tolerate therapy), and social support structure (home safety) to specific facility admission criteria.
Question 3270Question →

A 29-year-old woman is brought to the emergency department by her husband due to severe agitation, confusion, and palpitations that began earlier today. Her husband reports she has been increasingly irritable and has had profuse sweating and watery diarrhea for the past two days. She was diagnosed with a thyroid disorder three years ago but stopped taking her medications six months ago.

Vital signs are temperature 39.8°C (103.6°F), blood pressure 160/90 mm Hg, pulse 155/min and irregularly irregular, and respirations 24/min. Physical examination reveals a distressed, diaphoretic woman. A diffuse, non-tender goiter is palpable. Eye examination shows mild exophthalmos and lid retraction. Neurologic examination is notable for a fine resting tremor and brisk deep tendon reflexes. Electrocardiogram confirms atrial fibrillation with a rapid ventricular response. The patient's clinical presentation is highly consistent with a life-threatening endocrine emergency.

Which of the following pharmacologic interventions should be administered simultaneously as part of the immediate, initial therapeutic regimen? (Select 3)

Select all that apply

Show answer & explanation

Answer: Intravenous propranolol; Oral propylthiouracil; Intravenous hydrocortisone

Answer

The correct interventions are intravenous propranolol, oral propylthiouracil, and intravenous hydrocortisone.
The correct immediate bundle consists of intravenous propranolol, oral propylthiouracil, and intravenous hydrocortisone. Propranolol rapidly controls adrenergic symptoms and blocks peripheral T4 to T3 conversion. Propylthiouracil blocks de novo thyroid hormone synthesis and also blocks peripheral conversion. Hydrocortisone further inhibits peripheral conversion and treats the relative adrenal insufficiency often precipitated by the hypermetabolic state of thyroid storm. These three agents must be given simultaneously upon recognition of the syndrome.

Step-by-Step Solution

1
Identify the clinical syndrome based on the patient's presentation.
The combination of hyperpyrexia, severe tachycardia, agitation, goiter, exophthalmos, and GI distress points to thyroid storm.
Recognizing this life-threatening endocrine emergency is required to initiate the specific, rapid-acting multi-drug protocol.
2
Determine the therapeutic goals of immediate pharmacologic management.
The immediate goals are blocking peripheral adrenergic effects, halting new hormone synthesis, and preventing peripheral conversion of T4 to T3.
These mechanisms collectively blunt the systemic toxicity of excess thyroid hormone as quickly as possible.
3
Select the medications that achieve these goals safely while avoiding contraindicated agents.
Propranolol, propylthiouracil, and hydrocortisone fulfill these criteria and are given immediately. Potassium iodide and amiodarone are withheld.
Simultaneous administration of these three agents maximizes the blockade of hormone synthesis and effect while respecting the physiologic contraindications of early iodine administration.

Key Concept

The immediate multimodal pharmacologic management of thyroid storm requires simultaneous administration of a beta-blocker, a thionamide, and a glucocorticoid, while strictly delaying iodine therapy.
Question 3271Question →

A 6868-year-old woman is brought to the emergency department from a skilled nursing facility due to altered mental status and fever. Her temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 74/42 mm Hg74/42\text{ mm Hg}, pulse is 128/min128/\text{min}, and respiratory rate is 24/min24/\text{min}. Oxygen saturation is 94%94\% on room air. Physical examination reveals dry mucous membranes and cloudy, malodorous urine in her Foley catheter. Laboratory studies show a leukocyte count of 18,500/mm318,500/\text{mm}^3 and a serum lactate level of 6.2 mmol/L6.2\text{ mmol/L}. Blood and urine cultures are obtained, and broad-spectrum intravenous antibiotics are initiated.

Assuming the patient's hemodynamic instability persists despite each consecutive intervention, arrange the following therapies in the correct guideline-concordant sequence for the escalating management of her septic shock.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for escalating pharmacologic therapy in septic shock is: 1) Intravenous rapid crystalloid bolus, 2) Continuous intravenous norepinephrine infusion, 3) Continuous intravenous vasopressin infusion, 4) Intravenous hydrocortisone.
The standard protocol for escalating hemodynamic support in septic shock involves a highly specific sequence designed to optimize perfusion while minimizing drug toxicity. After securing source control and administering broad-spectrum antibiotics, hemodynamic resuscitation must always begin with a rapid fluid bolus of 30 mL/kg30\text{ mL/kg} of crystalloids. This corrects the relative hypovolemia induced by systemic inflammatory vasodilation. If the mean arterial pressure (MAP) fails to stabilize at ≥65 mm Hg\geq 65\text{ mm Hg} after adequate volume expansion, continuous intravenous norepinephrine is established as the first-line vasopressor. If hypotension persists despite escalating doses of norepinephrine, vasopressin is added as a second-line agent; this capitalizes on an alternative receptor pathway (V1V_1 receptors) to augment MAP while sparing the patient from the profound ischemic and arrhythmogenic side effects of high-dose catecholamines. Finally, if the patient remains hemodynamically unstable despite adequate fluids and dual vasopressor therapy, intravenous hydrocortisone is administered to treat potential relative adrenal insufficiency and upregulate vascular adrenergic receptors.

Step-by-Step Solution

1
Recognize septic shock and initiate fluid resuscitation.
Administer 30 mL/kg of intravenous balanced crystalloids.
Hypovolemia resulting from profound vasodilation and capillary leak must be corrected first to optimize cardiac preload before utilizing vasoactive agents.
2
Assess hemodynamic response to fluids; if mean arterial pressure (MAP) remains below 65 mm Hg, start a first-line vasopressor.
Initiate continuous intravenous norepinephrine.
Norepinephrine is the vasopressor of choice in septic shock due to its strong alpha-1 agonist properties, effectively increasing systemic vascular resistance with modest beta-1 inotropic support.
3
Evaluate response to primary vasopressor therapy; if MAP remains inadequate or high doses are required, escalate with a second-line pressor.
Add continuous intravenous vasopressin.
Relative vasopressin deficiency can occur in severe sepsis. Adding vasopressin helps achieve target blood pressure while simultaneously providing a catecholamine-sparing effect to reduce norepinephrine toxicity.
4
Identify refractory shock requiring multiple or escalating vasopressors.
Administer intravenous hydrocortisone.
Corticosteroids address critical illness-related corticosteroid insufficiency (CIRCI) and sensitize the vasculature to endogenous and exogenous catecholamines. They are reserved for fluid- and vasopressor-refractory shock.

Key Concept

The management of septic shock follows a strict algorithmic escalation: adequate volume resuscitation with crystalloids, followed by norepinephrine as the first-line vasopressor, the addition of vasopressin for refractory hypotension or catecholamine-sparing, and finally intravenous corticosteroids for persistent vasopressor-refractory shock.
Question 3272Question →

A 7878-year-old man is evaluated for discharge planning. He was admitted one week ago for fever and severe localized lower back pain and was subsequently diagnosed with methicillin-susceptible *Staphylococcus aureus* (MSSA) vertebral osteomyelitis of L3-L4. He has been treated with intravenous cefazolin. He is now afebrile, hemodynamically stable, and his back pain has significantly improved. He requires an additional five weeks of intravenous antibiotic therapy. His medical history is significant for hypertension and moderate Alzheimer dementia. Prior to admission, he lived alone, and his son visited on weekends to help with chores. The patient is able to ambulate independently with a cane, which is his baseline, and is independent in basic activities of daily living such as eating and dressing. However, he is oriented only to person, has significant short-term memory deficits, and requires supervision for medication administration. Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Transfer to a skilled nursing facility

Answer

The most appropriate disposition is transfer to a skilled nursing facility.
This patient requires five more weeks of intravenous antibiotics for vertebral osteomyelitis. Although he is medically stable for discharge from the acute care hospital, his moderate Alzheimer dementia and living situation (living alone with limited support) make a discharge home with outpatient parenteral antimicrobial therapy (OPAT) unsafe. He requires daily skilled nursing care for intravenous medication administration and monitoring, which is appropriately provided in a skilled nursing facility.

Step-by-Step Solution

1
Assess the patient's ongoing medical needs.
The patient requires five more weeks of intravenous antibiotics for vertebral osteomyelitis.
Determines the level of skilled care required.
2
Evaluate the patient's functional and cognitive status.
He is at his physical baseline but has moderate dementia with short-term memory deficits.
Determines rehabilitation needs and capacity for self-care.
3
Assess the patient's social support and home environment.
He lives alone with only weekend visits from family.
Determines if home discharge is safe.
4
Match the combined needs to the appropriate care setting.
Skilled nursing facility (SNF) provides the necessary daily skilled nursing (IV administration) for a patient who is physically stable but cognitively unsafe for home treatment.
Identifies the correct disposition pathway.

Key Concept

Patients who require prolonged intravenous antibiotics but lack the cognitive capacity and caregiver support to safely manage outpatient parenteral antimicrobial therapy (OPAT) at home should be transitioned to a skilled nursing facility.
Question 3273Question →

A 50-year-old man comes to the clinic to establish care. He has not been evaluated by a healthcare provider in 15 years and has not received any routine medical care or screenings during this time. He generally feels well and takes no medications. He smokes 1 pack of cigarettes daily for the past 30 years and drinks 2 to 3 alcoholic beverages on weekends. He is sexually active with men and uses condoms inconsistently. His BMI is 25 kg/m². Vital signs are within normal limits. Physical examination reveals no abnormalities.

Which of the following preventive interventions are indicated for this patient at this visit? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Annual low-dose computed tomography of the chest; Screening colonoscopy

Answer

Annual low-dose computed tomography of the chest and screening colonoscopy
The correct interventions are annual low-dose computed tomography (LDCT) of the chest and screening colonoscopy. According to current USPSTF guidelines, adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years require annual lung cancer screening with LDCT. This patient is 50 years old with a 30 pack-year history, making him an ideal candidate. Additionally, colorectal cancer screening is recommended for average-risk adults beginning at age 45. Since the patient has not received any medical care in 15 years, he is overdue for a screening colonoscopy.

Step-by-Step Solution

1
Analyze patient demographics and health history.
The patient is a 50-year-old male with a 30 pack-year smoking history who has not received medical care in 15 years.
Preventive screening interventions are strictly guided by age, biological sex, exposure history, and past screening dates.
2
Apply evidence-based guidelines for a 50-year-old male current smoker.
Lung cancer screening is indicated due to age (50) and pack-year history (>20). Colorectal cancer screening is indicated as it starts at age 45 and the patient is unscreened.
Identifying interventions that are currently indicated based on USPSTF guidelines.
3
Evaluate remaining options against current age cutoffs and indications.
Abdominal aortic aneurysm screening is for ages 65-75. HPV vaccination is not recommended after age 45. Dual-energy x-ray absorptiometry is not routinely indicated for men.
Ruling out distractors involving incorrect start/stop ages or unindicated tests.

Key Concept

Age-appropriate and risk-based preventive screening guidelines for adults
Question 3274Question →

A 28-year-old man is brought to the emergency department by emergency medical services 15 minutes after sustaining a stab wound to the left chest during an altercation. The wound is located at the left 5th intercostal space, just medial to the midclavicular line. On arrival, he is lethargic but responsive to painful stimuli. His temperature is 36.8°C (98.2°F), blood pressure is 76/40 mmHg, pulse is 132/min, and respirations are 26/min. Physical examination reveals distended jugular veins. The trachea is midline, and breath sounds are clear and equal bilaterally. Heart sounds are muffled. Which of the following procedural and management interventions are immediately indicated for this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Performance of a bedside focused assessment with sonography in trauma (FAST) examination; Immediate transfer to the operating room for surgical exploration

Answer

The indicated interventions are performing a bedside focused assessment with sonography in trauma (FAST) examination and immediately transferring the patient to the operating room for surgical exploration.
The correct interventions focus on rapid, non-invasive confirmation of the diagnosis and definitive surgical repair. A bedside FAST examination is the standard of care for rapidly identifying pericardial effusion in an unstable trauma patient. Once tamponade is confirmed in the setting of penetrating trauma, immediate surgical exploration (usually via sternotomy or thoracotomy) is mandatory to evacuate the blood and repair the myocardial defect.

Step-by-Step Solution

1
Analyze the patient's mechanism of injury and vital signs.
The patient has a penetrating injury in the 'cardiac box' and is hemodynamically unstable (hypotensive, tachycardic).
Identifying the severity of shock guides the urgency of interventions and rules out time-consuming diagnostic tests.
2
Correlate physical examination findings to formulate the primary diagnosis.
The presence of Beck's triad (hypotension, distended jugular veins, muffled heart sounds) alongside equal breath sounds and a midline trachea points to acute cardiac tamponade, not a tension pneumothorax.
Accurate clinical diagnosis differentiates between competing life-threatening thoracic emergencies.
3
Determine the appropriate diagnostic and therapeutic interventions.
A bedside FAST exam should be performed immediately to confirm pericardial fluid, followed by urgent transfer to the operating room for definitive surgical repair.
Unstable patients require interventions that can be performed at the bedside (FAST) and definitive anatomical correction (surgery).
4
Identify and avoid contraindicated actions.
Do not intubate with positive pressure before decompression, and do not send the patient to the CT scanner.
Positive pressure ventilation severely impairs right heart filling in tamponade, and CT imaging delays life-saving surgery in an unstable patient.

Key Concept

The immediate management of penetrating cardiac trauma with tamponade requires rapid bedside diagnosis via a FAST exam and definitive surgical exploration, while strictly avoiding interventions that decrease venous return (like positive pressure ventilation) or delay definitive care (like CT imaging).
Question 3275Question →

A 7171-year-old woman presents to her primary care physician for a scheduled medication management visit. She has a documented history of severe postmenopausal osteoporosis, which was complicated by a painful L2L2 vertebral compression fracture two years ago. At that time, a dual-energy x-ray absorptiometry (DEXA) scan revealed a T-score of −3.5-3.5 at the lumbar spine, and she was subsequently initiated on daily subcutaneous teriparatide therapy. She has been fully compliant with the medication and reports no new bone pain, back pain, or falls. Today marks exactly 2424 months of continuous teriparatide treatment.

Current laboratory studies:
Calcium: 9.5 mg/dL9.5 \text{ mg/dL}
Phosphorus: 3.6 mg/dL3.6 \text{ mg/dL}
Creatinine: 0.8 mg/dL0.8 \text{ mg/dL}
Alkaline phosphatase: 115 U/L115 \text{ U/L}
2525-hydroxyvitamin D: 45 ng/mL45 \text{ ng/mL}

A repeat DEXA scan performed this week demonstrates a T-score of −2.3-2.3 at the lumbar spine and −2.5-2.5 at the total hip.

Which of the following is the most appropriate next step in the management of this patient's osteoporosis?

Show answer & explanation

Answer: Discontinue teriparatide and initiate oral alendronate therapy

Answer

The patient should have teriparatide discontinued and immediately begin an antiresorptive agent, such as oral alendronate, to preserve her bone mineral density.
The correct course of action is to stop the anabolic agent and immediately begin an antiresorptive agent. Teriparatide is a recombinant fragment of human parathyroid hormone that powerfully stimulates bone formation. However, its use is strictly capped at a cumulative lifetime duration of 24 months. Furthermore, because teriparatide does not embed into the bone matrix, its discontinuation triggers an accelerated phase of bone resorption. To preserve the bone architecture and density gained during the 24-month anabolic window, clinical guidelines mandate sequential therapy with a potent antiresorptive medication, such as a bisphosphonate (e.g., alendronate) or denosumab.

Step-by-Step Solution

1
Evaluate the current duration and status of the patient's pharmacological therapy.
The patient has completed exactly 24 months of teriparatide, which is the maximum lifetime duration recommended.
Teriparatide (a parathyroid hormone analog) must be stopped at 24 months due to long-term safety concerns (e.g., theoretical osteosarcoma risk) and lack of efficacy data beyond this timeframe.
2
Determine the physiologic consequence of stopping the current medication.
Unlike bisphosphonates, anabolic agents do not persist in the bone matrix. Stopping teriparatide results in a rapid decline in bone mineral density (BMD).
Withdrawal of the anabolic stimulus leads to accelerated osteoclast-mediated bone resorption.
3
Select the appropriate sequential pharmacological intervention.
Initiate an antiresorptive agent (such as a bisphosphonate or denosumab).
Antiresorptive therapy must follow anabolic therapy to lock in and consolidate the substantial BMD gains achieved over the preceding two years.

Key Concept

Patients completing a 2-year course of an anabolic agent (e.g., teriparatide) must be sequentially transitioned to an antiresorptive agent (e.g., alendronate or denosumab) to prevent rapid bone loss and maintain fracture risk reduction.
Question 3276Question →

An 58-year-old male resident of an assisted living facility is evaluated in the emergency department due to a two-day history of frequent falls and worsening gait unsteadiness. Staff members also note that he has become increasingly confused. His medical history includes post-traumatic epilepsy, heart failure, and decompensated cirrhosis. His current medications are phenytoin, spironolactone, furosemide, and lactulose. He reports adhering to his regimen and has two to three soft bowel movements daily. On physical examination, he is alert but disoriented to time and place. Neurologic evaluation reveals prominent horizontal nystagmus on bilateral lateral gaze and a broad-based, unsteady gait. Asterixis is absent.

Laboratory results are as follows:

Laboratory TestResultReference Range
Sodium136 mEq/L136\ \text{mEq/L}136−145 mEq/L136-145\ \text{mEq/L}
Creatinine0.9 mg/dL0.9\ \text{mg/dL}0.7−1.3 mg/dL0.7-1.3\ \text{mg/dL}
Total bilirubin1.8 mg/dL1.8\ \text{mg/dL}0.1−1.2 mg/dL0.1-1.2\ \text{mg/dL}
Albumin1.9 g/dL1.9\ \text{g/dL}3.5−5.0 g/dL3.5-5.0\ \text{g/dL}
Phenytoin, total13 μg/mL13\ \mu\text{g/mL}10−20 μg/mL10-20\ \mu\text{g/mL}

Which of the following is the most appropriate next step in the monitoring and management of this patient?

Show answer & explanation

Answer: Obtain a serum free phenytoin concentration

Answer

Obtain a serum free phenytoin concentration
The correct answer requires recognizing the pharmacokinetic relationship between serum albumin and highly protein-bound medications. The patient exhibits classic, dose-dependent signs of phenytoin toxicity, which include horizontal nystagmus, ataxia, and altered mentation (confusion). Phenytoin is approximately 90%90\% bound to serum albumin. In states of significant hypoalbuminemia (such as advanced cirrhosis or nephrotic syndrome), there are fewer binding sites available. This results in a higher proportion of free, pharmacologically active phenytoin. Because standard laboratory assays measure *total* phenytoin (both the albumin-bound and the free unbound fractions), a total level that appears to be within the standard therapeutic range (10−20 μg/mL10-20\ \mu\text{g/mL}) can actually harbor a toxic concentration of the active free drug. The appropriate management step is to measure the serum free phenytoin level to accurately assess the extent of toxicity before making empirical dose adjustments or altering the medication regimen.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient presents with confusion, horizontal nystagmus, and ataxia.
These are the classic dose-dependent neurologic manifestations of phenytoin toxicity.
2
Evaluate the laboratory findings in the context of the patient's comorbidities.
The total serum phenytoin level is 13 μg/mL13\ \mu\text{g/mL} (within the normal reference range), but the serum albumin is markedly low at 1.9 g/dL1.9\ \text{g/dL}.
The patient's advanced cirrhosis has led to synthetic dysfunction and severe hypoalbuminemia.
3
Apply pharmacokinetic principles of monitoring to determine the next step.
Identify that phenytoin is extensively protein-bound ( 90%~90\%).
Because standard laboratory assays measure total phenytoin (bound + free), a normal total level in a patient with low albumin masks a disproportionately high and toxic level of free (active) phenytoin. A free phenytoin level must be measured to confirm the toxicity and guide dose adjustments.

Key Concept

In patients with marked hypoalbuminemia, highly protein-bound drugs like phenytoin have a larger unbound (active) fraction, meaning patients can experience severe clinical toxicity even when the total serum drug concentration appears within the normal therapeutic range.
Question 3277Question →

During morning rounds in the medical intensive care unit, a 2424-year-old man is evaluated. He was admitted 1818 hours ago with severe diabetic ketoacidosis. He has received aggressive fluid resuscitation and a continuous intravenous regular insulin infusion. Currently, he is asymptomatic, alert, and requesting breakfast. His most recent basic metabolic panel demonstrates a serum bicarbonate of 21 mEq/L21\text{ mEq/L} and an anion gap of 10 mEq/L10\text{ mEq/L}. Venous pH is 7.347.34. Point-of-care blood glucose is 175 mg/dL175\text{ mg/dL}. The care team decides it is time to transition him to a maintenance regimen of subcutaneous glargine and lispro insulin. Arrange the following steps in the most appropriate chronological sequence to safely accomplish this therapeutic transition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for transitioning a patient off an insulin infusion is to first administer the subcutaneous insulin, continue the intravenous infusion for a 1- to 2-hour overlap, then discontinue the intravenous infusion, and finally resume standard pre-meal blood glucose monitoring.
The clinically correct and safe sequence for resolving diabetic ketoacidosis involves waiting until resolution criteria are met (anion gap <12 mEq/L< 12\text{ mEq/L}, pH >7.3> 7.3, tolerating PO), which this patient has achieved. At this point, subcutaneous insulin is administered. Because intravenous insulin clears the body within minutes and subcutaneous insulin takes 11 to 22 hours to onset, a mandatory overlap of 11 to 22 hours is required. After this overlap, the intravenous infusion is stopped, and standard routine blood glucose monitoring continues.

Step-by-Step Solution

1
Administer the scheduled dose of subcutaneous basal and rapid-acting insulin.
The patient receives the first dose of their home subcutaneous insulin regimen while still on the intravenous infusion.
Subcutaneous insulin requires time for absorption and onset of action, making it the necessary first step in the transition protocol.
2
Maintain the continuous intravenous regular insulin infusion for 11 to 22 additional hours.
Intravenous and subcutaneous insulin delivery overlap for a critical safety window.
Intravenous insulin has a half-life of only a few minutes. Without an overlap period, insulin levels will drop to zero before the subcutaneous insulin begins working, risking a rapid relapse into ketoacidosis.
3
Discontinue the continuous intravenous regular insulin infusion.
The intravenous line delivering insulin is stopped.
Once the subcutaneous insulin has reached sufficient systemic levels (after the 1-2 hour overlap), the intravenous infusion is no longer needed and can be safely stopped.
4
Assess the point-of-care blood glucose prior to the patient's next meal.
Routine glucose monitoring is established.
With the acute crisis resolved and the patient on a standard regimen, monitoring safely transitions to standard pre-prandial and bedtime checks.

Key Concept

Patients recovering from diabetic ketoacidosis require a 1- to 2-hour overlap between the administration of subcutaneous insulin and the discontinuation of the intravenous insulin infusion to prevent rebound ketoacidosis.
Estimated Time:1m 30s
Question 3278Question →

An intensive care unit team assumes care of a 32-year-old male who was admitted overnight following an intentional overdose. Paramedics found empty prescription bottles for amitriptyline and clonazepam near him. The patient was intubated for airway protection shortly after arrival. Despite the administration of 3 liters of intravenous lactated Ringer solution over the past four hours, his blood pressure remains 76/40 mm Hg. His heart rate is 134/min. Physical examination is notable for widely dilated pupils, dry oral mucosa, and absent bowel sounds. The continuous cardiac monitor displays sinus tachycardia. A stat 12-lead electrocardiogram confirms a QRS duration of 152 ms, a prominent terminal R wave in lead aVR, and a QTc interval of 518 ms. Which of the following pharmacologic interventions are appropriate at this time? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Intravenous sodium bicarbonate; Intravenous norepinephrine

Answer

The correct interventions are intravenous sodium bicarbonate and intravenous norepinephrine.
The patient presents with life-threatening tricyclic antidepressant (TCA) toxicity, characterized by anticholinergic signs, fluid-refractory hypotension, and sodium channel blockade (demonstrated by a QRS duration > 100 ms). Intravenous sodium bicarbonate is indicated to overcome the sodium channel blockade by increasing the extracellular sodium gradient and alkalinizing the serum, which favors the non-ionized, less active form of the TCA. Intravenous norepinephrine is the vasopressor of choice for TCA-induced hypotension that is unresponsive to fluid resuscitation, as its potent alpha-1 agonist properties directly counteract the alpha-1 adrenergic receptor blockade caused by TCAs.

Step-by-Step Solution

1
Analyze the patient's toxidrome and presentation.
The patient exhibits severe anticholinergic toxicity (mydriasis, dry mucosa, absent bowel sounds) and cardiovascular collapse consistent with tricyclic antidepressant (TCA) overdose.
Identifying the specific agent driving the toxicity dictates the appropriate antidotal and supportive therapy.
2
Interpret the electrocardiogram findings.
The QRS widening (> 100 ms) and prominent terminal R wave in aVR indicate severe myocardial sodium channel blockade.
QRS duration > 100 ms is a definitive indication for serum alkalinization to prevent life-threatening ventricular arrhythmias.
3
Select the appropriate pharmacologic management for the hemodynamic and electrocardiographic abnormalities.
Intravenous sodium bicarbonate is chosen for the ECG abnormalities, and intravenous norepinephrine is chosen for the fluid-refractory hypotension.
Sodium bicarbonate increases the sodium gradient and favors the non-ionized form of the TCA. Norepinephrine directly counteracts the specific alpha-1 receptor blockade caused by TCAs.
4
Evaluate potential reversal agents for contraindications.
Physostigmine and flumazenil are identified as strictly contraindicated, and amiodarone is avoided.
Administering these agents in this specific clinical context will precipitate fatal complications (asystole, status epilepticus, or polymorphic ventricular tachycardia).

Key Concept

The management of severe tricyclic antidepressant (TCA) overdose requires intravenous sodium bicarbonate for QRS widening and norepinephrine for refractory hypotension, while strictly avoiding physostigmine, flumazenil, and Class I/III antiarrhythmics.
Question 3279Question →

A 68-year-old man with a history of ischemic cardiomyopathy (left ventricular ejection fraction 25%) and paroxysmal atrial fibrillation presents to the cardiology clinic for follow-up. Over the past month, he has experienced progressive fatigue and frequent palpitations. His current medications include sacubitril-valsartan, carvedilol, eplerenone, dapagliflozin, and apixaban. Vital signs today are within normal limits except for an irregular pulse of 118/min. An electrocardiogram confirms atrial fibrillation with a rapid ventricular response. Given his heavy symptomatic burden and underlying structural heart disease, the physician decides to initiate oral amiodarone for rhythm control. Which of the following baseline diagnostic studies are strictly indicated prior to or shortly after initiating this medication? (Select exactly 3 options)

Select all that apply

Show answer & explanation

Answer: Thyroid-stimulating hormone (TSH); Serum aminotransferases (ALT/AST); Pulmonary function testing with diffusion capacity for carbon monoxide (DLCO)

Answer

The necessary baseline diagnostic studies before initiating amiodarone are Thyroid-stimulating hormone (TSH), Serum aminotransferases (ALT/AST), and Pulmonary function testing with diffusion capacity for carbon monoxide (DLCO).
Amiodarone is a highly effective antiarrhythmic agent frequently used in patients with structural heart disease, but it carries a significant risk of systemic toxicity. Baseline evaluation is mandatory to establish reference values prior to exposure. Amiodarone is highly lipid-soluble and contains large amounts of iodine, leading to both hypothyroidism and hyperthyroidism; thus, baseline and periodic thyroid-stimulating hormone (TSH) monitoring is necessary. Hepatotoxicity can also occur, requiring baseline and ongoing serum aminotransferases (ALT/AST). Most critically, amiodarone pulmonary toxicity (APT) is a potentially fatal complication. Establishing a baseline with pulmonary function tests (PFTs), specifically including the diffusion capacity for carbon monoxide (DLCO), along with a standard chest radiograph, is crucial for future comparison if the patient develops respiratory symptoms.

Step-by-Step Solution

1
Identify the primary clinical intervention.
The patient is being initiated on oral amiodarone for symptomatic atrial fibrillation in the setting of structural heart disease.
Recognizing the specific pharmacotherapy dictates the subsequent baseline monitoring protocols.
2
Determine the end-organ toxicities associated with the initiated medication.
Amiodarone is known to cause pulmonary toxicity, hepatotoxicity, and thyroid dysfunction.
Understanding the adverse effect profile is necessary to select appropriate baseline investigations.
3
Select the guideline-recommended baseline studies corresponding to these toxicities.
Guidelines mandate baseline assessment of pulmonary function (PFTs with DLCO), hepatic function (LFTs), and thyroid function (TSH).
Establishing a baseline is critical for differentiating drug toxicity from underlying disease progression if symptoms develop later.
4
Rule out unnecessary tests and inappropriate drug interaction protocols.
Exclude PT/INR (patient is on apixaban, not warfarin), chest CT (chest X-ray is the appropriate baseline), and slit-lamp exam (only done if symptomatic).
Prevents overutilization of healthcare resources and misapplication of clinical guidelines.

Key Concept

Amiodarone Baseline and Ongoing Monitoring Requirements
Question 3280Question →

A 76-year-old woman is brought to the emergency department due to the sudden onset of severe abdominal pain that started 3 hours ago. Her medical history includes hypertension, hyperlipidemia, and paroxysmal atrial fibrillation. She stopped taking her prescribed apixaban one week ago prior to a dental extraction and did not resume it. Her temperature is 38.2°C (100.8°F), blood pressure is 82/50 mm Hg, pulse is 128/min and irregular, and respirations are 26/min. On physical examination, the abdomen is distended with board-like rigidity, diffuse tenderness to palpation, and marked rebound tenderness. Bowel sounds are absent.

Laboratory studies reveal:
TestResult
Leukocyte count22,000/mm³
Serum lactate6.1 mmol/L (Normal: 0.5–2.2 mmol/L)
pH7.28
pCO₂32 mm Hg
HCO₃⁻14 mEq/L

The patient is immediately started on aggressive intravenous fluid resuscitation, broad-spectrum antibiotics, and an intravenous heparin infusion. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Emergent exploratory laparotomy

Answer

Emergent exploratory laparotomy
This patient presents with classic signs of acute mesenteric ischemia (AMI), likely secondary to a superior mesenteric artery embolism (given her paroxysmal atrial fibrillation and recent cessation of apixaban). The classic presentation of AMI is severe abdominal pain out of proportion to physical exam findings. However, this patient has progressed to develop fever, hemodynamic instability (hypotension, tachycardia), severe lactic acidosis, and a rigid abdomen with rebound tenderness. These findings indicate transmural bowel infarction and peritonitis. In any patient with suspected AMI who develops peritonitis or hemodynamic instability, the most appropriate next step is emergent exploratory laparotomy. Surgery is required to resect necrotic bowel segments, restore mesenteric perfusion (e.g., via surgical embolectomy or bypass), and prevent overwhelming sepsis and death. Proceeding to the operating room takes precedence over confirmatory imaging.

Step-by-Step Solution

1
Identify the underlying diagnosis based on history and presentation.
The patient's history of atrial fibrillation off anticoagulation, sudden severe abdominal pain, and elevated lactate strongly suggest acute mesenteric ischemia due to arterial embolism.
Recognizing the primary pathology is essential for determining the specific treatment algorithm.
2
Assess the patient's clinical stability and abdominal exam findings.
The patient has hypotension, tachycardia, fever, and a rigid abdomen with rebound tenderness (peritonitis).
The presence of peritonitis indicates transmural bowel infarction and potential perforation, shifting the management from diagnostic to emergent therapeutic.
3
Select the appropriate intervention based on stability.
Emergent exploratory laparotomy is chosen over imaging.
Unstable patients with peritonitis require immediate surgery to resect necrotic tissue; delaying for imaging increases mortality.

Key Concept

Patients with suspected acute mesenteric ischemia who exhibit signs of peritonitis or hemodynamic instability require emergent exploratory laparotomy, bypassing diagnostic imaging.
Estimated Time:1m 30s
PreviousPage 164 / 237Next